Abacavir lamivudine: Difference between revisions

Revision as of 19:39, 9 January 2014

For patient information, click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

EPZICOM^®

@@ Line 1: / Line 1: @@
 __NOTOC__
+{{Abacavir lamivudine}}
+'''''For patient information, click <u>[[Abacavir lamivudine (patient information)|here]]</u>'''''.
+{{CMG}}
+==Overview==
+==Category==
+Antiretroviral
+==US Brand Names==
+EPZICOM<sup>®</sup>
+==FDA Package Insert==
+'''  [[Abacavir lamivudine description|Description]]'''
+'''| [[Abacavir lamivudine clinical pharmacology|Clinical Pharmacology]]'''
+'''| [[Abacavir lamivudine microbiology|Microbiology]]'''
+'''| [[Abacavir lamivudine indications and usage|Indications and Usage]]'''
+'''| [[Abacavir lamivudine contraindications|Contraindications]]'''
+'''| [[Abacavir lamivudine warnings and precautions|Warnings and Precautions]]'''
+'''| [[Abacavir lamivudine adverse reactions|Adverse Reactions]]'''
+'''| [[Abacavir lamivudine drug interactions|Drug Interactions]]'''
+'''| [[Abacavir lamivudine overdosage|Overdosage]]'''
+'''| [[Abacavir lamivudine clinical studies|Clinical Studies]]'''
+'''| [[Abacavir lamivudine dosage and administration|Dosage and Administration]]'''
+'''| [[Abacavir lamivudine how supplied|How Supplied]]'''
+'''| [[Abacavir lamivudine labels and packages|Labels and Packages]]'''
+==Mechanism of Action==
+==References==
+{{Reflist|2}}
+[[Category:Antiretroviral]]
+[[Category:Wikinfect]]